Source: International Congress 2018 – New developments in paediatric asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Gupta (London, United Kingdom), J. Steinfeld (Philadelphia, PA, United States of America), R. Price (Stevenage, Hertfordshire, United Kingdom), J. Azmi (Stockley Park, Uxbridge, United Kingdom), E. Bradford (Research Triangle Park, NC, United States of America), S. Yancey (Research Triangle Park, NC, United States of America). Mepolizumab for severe eosinophilic asthma: a comparison of efficacy in children, adolescents, and adults. 5447

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of tezepelumab in adolescents with severe, uncontrolled asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Severe asthma in children: more than little adults Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 A genome-wide association study of severe asthma exacerbations in Latino children and adolescents Source: Eur Respir J, 57 (4) 2002693; 10.1183/13993003.02693-2020 Year: 2021 Novel therapies for severe asthma in children and adults Source: Breathe, 14 (1) 59; 10.1183/20734735.018917 Year: 2018 Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021 Asthma in school-aged children and adolescents Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=191 Year: 2006 Different inflammatory phenotypes in adults and children with acute asthma Source: Eur Respir J 2011; 38: 567-574 Year: 2011 The prevalence of asthma in children: a reversing trend Source: Eur Respir J 2005; 26: 647-650 Year: 2005 Asthma in pre-schoolers: difficult to treat Source: Annual Congress 2005 - Asthma in the preschool child Year: 2005 Anti-IgE treatment in children with severe intrinsic asthma Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Real-life effectiveness of anti-IL-5(-receptor) antibody treatment in patients with severe eosinophilic asthma Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Longitudinal patterns of asthma medication use in preschool children: results from the PIAMA-study Source: Annual Congress 2005 - Epidemiology in childhood asthma Year: 2005 Omalizumab (Xolair®) reduces exacerbations in adolescents more than in adults with allergic (IgE-mediated) asthma: a subgroup analysis of pooled clinical trials Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Infantile and preschool asthma Source: Eur Respir Monogr 2012; 56: 10-21 Year: 2012 The prevalence of atopic diseases in children of childhood asthmatic adults Source: Eur Respir J 2002; 20: Suppl. 38, 336s Year: 2002 The course of asthma in preschool children with asthma Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 Severe asthma in children Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Severe asthma in children Source: CME Online 2011 Year: 2011 Mepolizumab is effective in severe eosinophilic asthmatics: an Austrian real-life study. Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020